Brent Meadows
Chief Business Officer Senovia Biosciences
Seminars
Thursday 3rd December 2026
Horizon Scanning Roundtable: Where Could Amylin Biology Create Value Beyond Metabolic Disease?
12:00 pm
- Investigating amylin's potential in type 1 diabetes for glycemic control and hypoglycemia reduction
- Examining metabolic benefits for MASH, kidney disease, and cardiovascular outcomes
- Discussing speculative but intriguing indications: addiction, alcohol use disorder, sleep disorders, and Alzheimer's disease
